MedTrace Logo

Nursing Home Team-Care Deprescribing Study

NCT02863341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 295

Last updated 2018-04-05

No results posted yet for this study

Summary

This is a multi-centre study in Singapore nursing homes, investigating the factors that affecting deprescribing, and if a team-care based deprescribing standard practice gives superior health and pharmacoeconomic outcomes over current medication review practice.

Conditions

  • Fall in Nursing Home
  • Medication Therapy Management

Interventions

OTHER

Team-care deprescribing with deprescribing guide

Beers criteria 2015, STOPP criteria 2014, drug interaction

Sponsors & Collaborators

  • Monash University

    collaborator OTHER

  • National Healthcare Group, Singapore

    collaborator OTHER_GOV

  • Tan Tock Seng Hospital

    lead OTHER

Principal Investigators

  • Chong Han Kua · Monash University/Tan Tock Seng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-03-31
Completion
2018-04-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02863341 on ClinicalTrials.gov